
TY  - JOUR
TI  - Abstracts
JO  - Movement Disorders Clinical Practice
JA  - Mov Disord Clin Pract
VL  - 7
IS  - S1
SN  - 2330-1619
UR  - https://doi.org/10.1002/mdc3.12905
DO  - doi:10.1002/mdc3.12905
SP  - S13
EP  - S111
PY  - 2020
ER  - 

TY  - JOUR
TI  - Mini Oral Abstracts
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S4
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.12301
DO  - doi:10.1111/nep.12301
SP  - 17
EP  - 57
PY  - 2014
ER  - 

TY  - JOUR
TI  - 135th Annual Meeting Poster Session AbstractsMonday, September 13, 2010
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 68
IS  - S14
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.22175
DO  - doi:10.1002/ana.22175
SP  - S4
EP  - S62
PY  - 2010
ER  - 

TY  - JOUR
TI  - 6th World Congress for Hair Research
JO  - Experimental Dermatology
VL  - 19
IS  - 6
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2010.01097.x
DO  - doi:10.1111/j.1600-0625.2010.01097.x
SP  - 556
EP  - 616
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts of the 2nd Cancer Cachexia Conference, Montreal, Canada, 26–28 September 2014
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - J Cachexia Sarcopenia Muscle
VL  - 6
IS  - 1
SN  - 2190-5991
UR  - https://doi.org/10.1002/jcsm.12004
DO  - doi:10.1002/jcsm.12004
SP  - 2
EP  - 31
PY  - 2015
ER  - 

TY  - JOUR
TI  - 46th Annual Meeting of the Child Neurology Society
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 82
IS  - S21
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.25022
DO  - doi:10.1002/ana.25022
SP  - S235
EP  - S350
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 10
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.13033
DO  - doi:10.1111/jdi.13033
SP  - 24
EP  - 44
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 23
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13091
DO  - doi:10.1111/ene.13091
SP  - 21
EP  - 110
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Session Group I – Blue TPS 1
JO  - Allergy
JA  - Allergy
VL  - 70
IS  - S101
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12719
DO  - doi:10.1111/all.12719
SP  - 290
EP  - 392
PY  - 2015
ER  - 

TY  - JOUR
TI  - 189th Meeting of the Pathological Society of Great Britain and Ireland, Robinson College, Cambridge, 4-6 January 2006 (incorporating the Trainees' Forum)
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 208
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1957
DO  - doi:10.1002/path.1957
SP  - 1A
EP  - 35A
PY  - 2006
ER  - 

TY  - JOUR
AU  - Stehlik, Josef
AU  - Armstrong, Brian
AU  - Baran, David A.
AU  - Bridges, Nancy D.
AU  - Chandraker, Anil
AU  - Gordon, Robert
AU  - De Marco, Teresa
AU  - Givertz, Michael M.
AU  - Heroux, Alain
AU  - Iklé, David
AU  - Hunt, Judson
AU  - Kfoury, Abdallah G.
AU  - Madsen, Joren C.
AU  - Morrison, Yvonne
AU  - Feller, Erika
AU  - Pinney, Sean
AU  - Tripathi, Sudipta
AU  - Heeger, Peter S.
AU  - Starling, Randall C.
TI  - Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - 5
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15218
DO  - doi:10.1111/ajt.15218
SP  - 1518
EP  - 1528
KW  - alloantibody
KW  - clinical research/practice
KW  - heart (allograft) function/dysfunction
KW  - heart transplantation/cardiology
KW  - vasculopathy
PY  - 2019
AB  - Clinical Trials in Organ Transplantation-18 (CTOT-18) is a follow-up analysis of the 200-subject multicenter heart transplant CTOT-05 cohort. CTOT-18 aimed to identify clinical, epidemiologic, and biologic markers associated with adverse clinical events past 1 year posttransplantation. We examined various candidate biomarkers including serum antibodies, angiogenic proteins, blood gene expression profiles, and T cell alloreactivity. The composite endpoint (CE) included death, retransplantation, coronary stent, myocardial infarction, and cardiac allograft vasculopathy. The mean follow-up was 4.5 ± SD 1.1 years. Subjects with serum anti-cardiac myosin (CM) antibody detected at transplantation and at 12 months had a higher risk of meeting the CE compared to those without anti-CM antibody (hazard ratio [HR] = 2.9, P = .046). Plasma VEGF-A and VEGF-C levels pretransplant were associated with CE (odds ratio [OR] = 13.24, P = .029; and OR = 0.13, P = .037, respectively). Early intravascular ultrasound findings or other candidate biomarkers were not associated with the study outcomes. In conclusion, anti-CM antibody and plasma levels of VEGF-A and VEGF-C were associated with an increased risk of adverse events. Although this multicenter report supports further evaluation of the mechanisms through which anti-CM antibody and plasma angiogenesis proteins lead to allograft injury, we could not identify additional markers of adverse events or potential novel therapeutic targets.
ER  - 

TY  - JOUR
TI  - Program
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14304
DO  - doi:10.1111/ajt.14304
SP  - 5
EP  - 204
PY  - 2017
ER  - 

AU  - Fuller, Stephanie J.
AU  - Sohrabi, Hamid R.
AU  - Goozee, Kathryn G.
AU  - Sankaranarayanan, Anoop
AU  - Martins, Ralph N.
C7  - pp. 9-42
TI  - Alzheimer's Disease and Other Neurodegenerative Diseases
SN  - 9781119356783
UR  - https://doi.org/10.1002/9781119356752.ch2
DO  - doi:10.1002/9781119356752.ch2
SP  - 9-42
KW  - Alzheimer's disease
KW  - cardiovascular disease
KW  - disease pathology
KW  - lifestyle changes
KW  - neurodegenerative conditions
KW  - Parkinson's disease
KW  - type 2 diabetes
KW  - vascular dementia
PY  - 2017
AB  - Summary Neurodegenerative diseases are a heterogeneous group of disorders or conditions characterised by the progressive degeneration of the structure and function of the central nervous system or the peripheral nervous system. Some are considered to be caused by protein misfolding, some involve disruptions to intracellular processes such as mitochondrial function or protein degradation pathways, and some are genetic in origin. Whatever the original cause of the disease, the greatest risk factor for most of these diseases is increasing age. This book is mostly focused on Alzheimer's disease (AD), yet in this chapter we describe Alzheimer's as well as other major neurodegenerative conditions to demonstrate both similarities and differences.
ER  - 

TY  - JOUR
TI  - ISLH 2017 Abstract Proceedings
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 39
IS  - S2
SN  - 9781119356783
UR  - https://doi.org/10.1111/ijlh.12698
DO  - doi:10.1111/ijlh.12698
SP  - 3
EP  - 133
PY  - 2017
ER  - 

TY  - JOUR
TI  - Back to the Future Incorporating an Education Symposium Establishing a Para-Curriculum in Anatomy
JO  - Journal of Anatomy
JA  - J. Anat.
VL  - 230
IS  - 1
SN  - 9781119356783
UR  - https://doi.org/10.1111/joa.12488
DO  - doi:10.1111/joa.12488
SP  - 165
EP  - 195
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 24
IS  - 3
SN  - 9781119356783
UR  - https://doi.org/10.1111/exd.12623
DO  - doi:10.1111/exd.12623
SP  - E1
EP  - E50
PY  - 2015
ER  - 

TY  - JOUR
TI  - 36th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 18
IS  - 3
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1600-0625.2008.00834.x
DO  - doi:10.1111/j.1600-0625.2008.00834.x
SP  - 274
EP  - 333
PY  - 2009
ER  - 

TY  - JOUR
TI  - POSTER SESSION: CLINICAL
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 9781119356783
UR  - https://doi.org/10.1093/eurjhf/hst009
DO  - doi:10.1093/eurjhf/hst009
SP  - S73
EP  - S325
PY  - 2013
ER  - 

TY  - JOUR
TI  - BioIron Abstracts
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 88
IS  - 5
SN  - 9781119356783
UR  - https://doi.org/10.1002/ajh.23453
DO  - doi:10.1002/ajh.23453
SP  - E5
EP  - E243
PY  - 2013
ER  - 

TY  - JOUR
TI  - Concurrent Session 2: Monday 20 April Afternoon
JO  - Journal of Paediatrics and Child Health
JA  - J Paediatr Child Health
VL  - 51
IS  - S1
SN  - 9781119356783
UR  - https://doi.org/10.1111/jpc.12884_2
DO  - doi:10.1111/jpc.12884_2
SP  - 17
EP  - 35
PY  - 2015
ER  - 
